Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model
- 10 June 2023
- Vol. 41 (30) , 4402-4413
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31970178, 32000139, 32000140)
This publication has 62 references indexed in Scilit:
- Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand FlagellinPLOS ONE, 2010
- Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentVirology Journal, 2010
- Needle-free influenza vaccinationThe Lancet Infectious Diseases, 2010
- A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalationJournal of Controlled Release, 2010
- Seasonal and Pandemic Human Influenza Viruses Attach Better to Human Upper Respiratory Tract Epithelium than Avian Influenza VirusesThe American Journal of Pathology, 2010
- Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developmentsExpert Review of Vaccines, 2009
- Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutininsVaccine, 2008
- RecombinantBacillus subtilisExpressing theClostridium perfringensAlpha Toxoid Is a Candidate Orally Delivered Vaccine against Necrotic EnteritisInfection and Immunity, 2008
- Differential Cytokine Pattern in the Spleens and Livers of BALB/c Mice Infected withPenicillium marneffei: Protective Role of Gamma InterferonInfection and Immunity, 2003
- Fusion mutants of the influenza virus hemagglutinin glycoproteinCell, 1985